Ultragenyx Pharmaceutical Inc. (RARE): Depreciation & Amortization
$35.00M
Year ended 2025-12-31
+24.3%
3-year compound annual growth
+23.3%
5-year compound annual growth
+38.1%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $35.00M | -2.8% | 2026-02-18, From 2025-01-01 |
| 2024-12-31 | $36.00M | +38.5% | 2026-02-18, From 2024-01-01 |
| 2023-12-31 | $26.00M | +42.7% | 2026-02-18, From 2023-01-01 |
| 2022-12-31 | $18.22M | +37.6% | 2025-02-19, From 2022-01-01 |
| 2021-12-31 | $13.24M | +8.0% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $12.26M | +43.6% | 2023-02-17, From 2020-01-01 |
| 2019-12-31 | $8.54M | -56.3% | 2022-02-15, From 2019-01-01 |
| 2018-12-31 | $19.54M | +235.4% | 2021-02-12, From 2018-01-01 |
| 2017-12-31 | $5.83M | +70.1% | 2020-02-14, From 2017-01-01 |
| 2016-12-31 | $3.42M | +147.4% | 2019-02-20, From 2016-01-01 |
| 2015-12-31 | $1.38M | +102.3% | 2018-02-21, From 2015-01-01 |
| 2014-12-31 | $684.0K | +54.1% | 2017-02-17, From 2014-01-01 |
| 2013-12-31 | $444.0K | +41.9% | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | $313.0K | n/a | 2015-03-27, From 2012-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | $35.00M | -2.8% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $1.55M | -8.3% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $91.56M | +13.9% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $91.02M | +15.5% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $59.0K | -13.2% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $95.80M | -11.9% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $91.63M | -6.7% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $1.15M | +44.5% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $15.27M | +12.1% |
Compare RARE, KNSA, SUPN, PCRX side by side · Screen every company in Pharmaceutical Preparations ↗